ContinUse Biometrics secures $20 million for health-monitoring tech
ContinUse Biometrics, whose record enables people to detect a decrease in their health early on, pronounced on Tuesday it has cumulative $20 million in new appropriation from investors led by Singapore-based Chartered Group. The startup has grown a remote sensor that monitors some-more than 20 biomedical parameters remotely, including blood pressure, flesh activity and heart and lung sounds and even biochemical activity, with a earthy contact. It analyzes a information for patients or physicians by regulating synthetic intelligence. The association says it can even be used to guard drivers and urge highway safety. Funded 3 years ago by CEO Asher Polani and 4 others, ContinUse was innate out of a decade-long collaborative bid between Israel’s Bar-Ilan University and Spain’s University of Valencia. The latest turn brings appropriation to date for a Tel Aviv-based association to $27 million from investors that embody Olive Tree Ventures, mechanism builder Lenovo organisation and Johnson Controls/Tyco. (TheMarker Staff)
BioCatch nabs $30 million for ‘biometric authentication’
BioCatch, a U.S./Israeli startup that has grown what it calls “behavioral biometric authentication and hazard detection” record to capacitate businesses to frustrate online rascal before it happens, pronounced on Monday it sealed on a $30 million fundraising round. Maverick Ventures, an Israeli fund, led a financier group, assimilated by American Express, a crowd-funding height Our Crowd and others. The association takes a novel proceed to mechanism security. Instead of manufacture barriers, like passwords, it focuses on users’ online function to brand and forestall a intensity fraudster. That includes some-more than 2,000 cognitive parameters, such as a approach a user wiggles his or her rodent when a cursor disappears. The latest turn brings BioCatch’s fundraising to $47 million given it was founded in 2011 by Chief Technology Officer Avi Turgeman and Uri Rivner, a company’s conduct of cyberstrategy. It depends as business Royal Bank of Scotland and American Express. (Eliran Rubin)
Rambam to combine with Stanford on next-generation medical technology
We’ve got some-more newsletters we consider you’ll find interesting.
Click here
Please try again later.
The email residence we have supposing is already registered.
Close
The Rambam Health Care Campus in Haifa and Stanford Medicine have reached an agreement to work together on a destiny of medicine. In an proclamation on Friday during a discussion on Planning for a Next Generation, a dual pronounced they would combine in medical innovation, large information and appurtenance learning, cutting-edge drug development, and mishap and puncture preparedness. “During a discussion we discussed precise, personalized health issues and a emanate of health in Israel, including a formidable family in Israel between a internal different race and with a neighbors,” Prof. Rafi Beyar, a executive of Rambam, pronounced in a statement. Rambam is a informal sanatorium with 1,000 beds, 130,000 visits a year to a puncture room, and an annual bill of $400 million. Stanford is a 600-bed sanatorium with 60,000 visits to a puncture room annually and a bill of $7 billion a year. (JTA)
Eucalyptus account partners assured notwithstanding being brief of fundraising goal
Eucalyptus, a new try collateral account shaped by Eldad Tamir and Dedi Perlmutter, is still brief of a 400 million shekels ($117 million) it needs for it to validate for supervision backing, though a dual told TheMarker in an talk they believed a account is a good approach for tiny investors to distinction from Israeli high tech in a approach that wasn’t probable before. Five supports that were shaped underneath a supervision module face a Jun deadline to lift a smallest volume though have reportedly brought in no some-more than 300 million shekels to date. If they accommodate a minimum, a state will yield word covering adult to 50 million shekels in waste and yield supervision guarantees on loans. Tamir blamed disastrous media coverage for a failure. “Among other things a media broken a product. No one sat with us and listened [to the case],” he said. “The banks didn’t assistance possibly by deeming us a unsure [investment product].” (Assa Sasson and Eliran Rubin)